Health

Biotechnology

  • United States
    The Interconnections of Science and Foreign Policy
    Play
    In the inaugural launch of this new forum on science and foreign policy, U.S. State Department science envoys—specializing in fusion energy, ocean sustainability, and quantum technology—discuss the relationship between science and U.S. foreign policy in addressing global challenges through collaboration, and ways policymakers can support these efforts more effectively.   Established in 2024, the Norman E. Alexander Family M Foundation Forum on Science and Foreign Policy is an endowed annual event that explores the interconnections among the natural sciences, emerging technologies, and foreign policy and national security. It was made possible through the generosity of the Norman E. Alexander Family M Foundation in recognition of Mr. Alexander’s lifelong engagement in all manner of discourse for the betterment of humanity. The forum provides a unique platform for interdisciplinary knowledge-sharing among scientists and foreign policy experts. 
  • United States
    In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries
    Play
    The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.   Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.
  • Biotechnology
    Bernard L. Schwartz Annual Lecture on Economic Growth and Foreign Policy With Tony Coles
    Play
    Drawing from his distinguished career in the pharmaceutical industry, Cerevel Therapeutics Chairman and former CEO Tony Coles discusses developments in biotechnology, the implications of health policy on economic security, and leadership lessons learned throughout his career.  The Bernard L. Schwartz Annual Lecture on Economic Growth and Foreign Policy series focuses on two areas: the evolution of the relationship between business and government in the making of foreign policy, and ways for government to make better use of business in solving foreign policy problems.

Experts in this Topic

Luciana Borio Headshot
Luciana L. Borio

Senior Fellow for Global Health

James P. Dougherty

Adjunct Senior Fellow for Business and Foreign Policy